ASKA Pharmaceutical Holdings (4886.T) Earnings Analysis
ASKA Pharmaceutical Holdings (4886.T) has no confirmed upcoming earnings date. It has beaten estimates in 1/1 recent quarters (100%). Trailing P/E 11.58.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 4886.T next report earnings?
No confirmed upcoming earnings date is currently scheduled for 4886.T. This page updates as the calendar is published.
4886.T earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-11 | 53.53 JPY | n/a | n/a | n/a |
| 2026-02-02 | 59.1 JPY | n/a | n/a | n/a |
| 2025-08-04 | 43.88 JPY | n/a | n/a | n/a |
| 2025-05-12 | 35.36 JPY | n/a | n/a | n/a |
| 2025-02-03 | 54.23 JPY | n/a | n/a | n/a |
| 2024-08-05 | 44.94 JPY | 43.8 JPY | +2.6% | Beat |
Beat rate: 1/1 (100%) over reported quarters with consensus data.
4886.T valuation and analyst view
| Trailing P/E | 11.58 |
|---|---|
| Trailing EPS | 191.07 JPY |
| Price / book | 0.90 |
| Dividend yield | 2.71% |
| Market cap | 63.12B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is ASKA Pharmaceutical Holdings (4886.T)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 4886.T. This page updates as the calendar is published.
Did 4886.T beat earnings last quarter?
Consensus estimate data was not available for 4886.T's 2026-05-11 report.
What is 4886.T's earnings track record?
Over the last 1 reported quarters with consensus data, 4886.T beat estimates 1 times (100%).
What is 4886.T's current P/E ratio and EPS?
4886.T trades at a trailing P/E of 11.58 on trailing EPS of 191.06822104039728 JPY.
What do analysts rate 4886.T?
4886.T has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.